K160829

Substantially Equivalent

illumigene Mycoplasma Direct DNA Amplification Assay, illumigene Mycoplasma Direct External Controls, illumipro-10

Applicant: Meridian Bioscience, Inc.
Product code: OZX
Advisory panel: Microbiology
Date received: 2016-03-25
Decision date: 2016-06-13
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Cincinnati, OH, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.